All Stories

  1. Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

    Article • Pharmacogenomics and Personalized Medicine, September 2019, Taylor & Francis

    Vorapun Senanarong, Dr Pornpimol Kijsanayotin

  2. Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease

    Article • November 2018, Dove Medical Press

    Dr Giau Van Vo, Dr Seong Soo A An, Professor SangYun Kim, Vorapun Senanarong

  3. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

    Article • Clinical Interventions in Aging, April 2017, Dove Medical Press

    IRENE LOOI, Encarnita Ampil, Vorapun Senanarong